Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Share buy-back programme schedule for H2 2024.pdfShare buy-back programme schedule for H2 2024

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 28 / 2024
Date of issue: 2024-05-24
Short name of the issuer
KRKA
Subject
Share buy-back programme schedule for H2 2024
Official market - legal basis
Unofficial market - legal basis
Contents of the report:
Based on the provisions of Article 26 of the Ljubljana Stock Exchange Rules, Article 158 of the Market in Financial Instruments Act, article 2 of the Commission Delegated regulation (EU) No 2016/2052 and Article 17 of Regulation (EU) No 596/2014, Krka, d. d., Novo mesto (hereinafter: Krka) discloses information regarding share buy-back programme (hereinafter: programme) schedule from July to December 2024.

Krka disclosed the start of the share buy-back programme on 20 July 2023 through the electronic dissemination system SEOnet.

The programme schedule for H2 2024 is attached.

The public will be regularly informed about these acquisitions of treasury shares.


This announcement will be published on the company’s website (www.krka.biz) starting from 24 May 2024, for a minimum period of 5 years.
Annexes
File Description
Share buy-back programme schedule for H2 2024.pdf
Share buy-back programme schedule for H2 2024.pdf		 Share buy-back programme schedule for H2 2024

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2024-05-24 Jože Colarič President of the Management Board and CEO
20240524_091635_1902819612_Share_buy-back_programme_schedule_for_H2_2024.pdf

Pobierz